Adding 64cu radiopharmaceuticals to the toolkit of molecular imaging

There is no doubt that one of the most potent driving forces for the advancement of nuclear medicine springs from the introduction of efficient methods for the production of novel radionuclides having unprecedented nuclear properties for medical applications. Usually, this is a long and uneven process that involves the contribution of many different specialties, but it is essential to demonstrate the potential of a novel radionuclide to address fundamental clinical questions and to add further value to the existing arsenal of diagnostic and therapeutic radiopharmaceuticals